OpenAlex is a bibliographic catalogue of scientific papers, authors and institutions accessible in open access mode, named after the Library of Alexandria. It's citation coverage is excellent and I hope you will find utility in this listing of citing articles!
If you click the article title, you'll navigate to the article, as listed in CrossRef. If you click the Open Access links, you'll navigate to the "best Open Access location". Clicking the citation count will open this listing for that article. Lastly at the bottom of the page, you'll find basic pagination options.
Requested Article:
Antiviral therapy for COVID-19: Derivation of optimal strategy based on past antiviral and favipiravir experiences
Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108121-108121
Open Access | Times Cited: 30
Kimiyasu Shiraki, Noriaki Sato, Kaoru Sakai, et al.
Pharmacology & Therapeutics (2022) Vol. 235, pp. 108121-108121
Open Access | Times Cited: 30
Showing 1-25 of 30 citing articles:
How to use COVID-19 antiviral drugs in patients with chronic kidney disease
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Ajinath Kale, Vishwadeep Shelke, Neha Dagar, et al.
Frontiers in Pharmacology (2023) Vol. 14
Open Access | Times Cited: 20
Development of favipiravir dry powders for intranasal delivery: An integrated cocrystal and particle engineering approach via spray freeze drying
Si Nga Wong, Si Li, Kam‐Hung Low, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123896-123896
Closed Access | Times Cited: 6
Si Nga Wong, Si Li, Kam‐Hung Low, et al.
International Journal of Pharmaceutics (2024) Vol. 653, pp. 123896-123896
Closed Access | Times Cited: 6
Eco-sustainable chromatographic method for the determination of favipiravir and nitazoxanide for COVID-19: application to human plasma
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
Amal B. Ahmed, Maha M. Abdelrahman, Fadwa H. Edrees
BMC Chemistry (2025) Vol. 19, Iss. 1
Open Access
A Comprehensive Review on the Efficacy of Several Pharmacologic Agents for the Treatment of COVID-19
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Fatma Haddad, Ghadeer Dokmak, Rafik Karaman
Life (2022) Vol. 12, Iss. 11, pp. 1758-1758
Open Access | Times Cited: 22
Molecules for COVID-19 treatment
Zhigang Zeng, Changzhou Liao, Lei Yu
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109349-109349
Closed Access | Times Cited: 14
Zhigang Zeng, Changzhou Liao, Lei Yu
Chinese Chemical Letters (2023) Vol. 35, Iss. 7, pp. 109349-109349
Closed Access | Times Cited: 14
Rapid development and mass production of SARS-CoV-2 neutralizing chicken egg yolk antibodies with protective efficacy in hamsters
Binan Zhao, Haoran Peng, Yanjing Zhang, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 3
Binan Zhao, Haoran Peng, Yanjing Zhang, et al.
Biological Research (2024) Vol. 57, Iss. 1
Open Access | Times Cited: 3
The preclinical discovery and development of molnupiravir for the treatment of SARS-CoV-2 (COVID-19)
Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 12, pp. 1299-1311
Closed Access | Times Cited: 15
Pasquale Pagliano, Carmine Sellitto, Tiziana Ascione, et al.
Expert Opinion on Drug Discovery (2022) Vol. 17, Iss. 12, pp. 1299-1311
Closed Access | Times Cited: 15
Novel analogues of a nonnucleoside SARS-CoV-2 RdRp inhibitor as potential antivirotics
L Tóth, Kateřina Krejčová, Milan Dejmek, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1029-1036
Open Access | Times Cited: 2
L Tóth, Kateřina Krejčová, Milan Dejmek, et al.
Beilstein Journal of Organic Chemistry (2024) Vol. 20, pp. 1029-1036
Open Access | Times Cited: 2
An Overview of SARS-CoV-2 Potential Targets, Inhibitors, and Computational Insights to Enrich the Promising Treatment Strategies
Pooja Kumawat, Lokesh Kumar Agarwal, Kuldeep Sharma
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 2
Pooja Kumawat, Lokesh Kumar Agarwal, Kuldeep Sharma
Current Microbiology (2024) Vol. 81, Iss. 7
Closed Access | Times Cited: 2
Xuanfei Baidu decoction in the treatment of coronavirus disease 2019 (COVID-19): Efficacy and potential mechanisms
Tiantian Meng, Jingyi Ding, Shu-Jie Shen, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19163-e19163
Open Access | Times Cited: 5
Tiantian Meng, Jingyi Ding, Shu-Jie Shen, et al.
Heliyon (2023) Vol. 9, Iss. 9, pp. e19163-e19163
Open Access | Times Cited: 5
Convenient screening of the reproductive toxicity of favipiravir and antiviral drugs in Caenorhabditis elegans
Kimiyasu Shiraki, Mizuki Mishima, Noriaki Sato, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35331-e35331
Open Access | Times Cited: 1
Kimiyasu Shiraki, Mizuki Mishima, Noriaki Sato, et al.
Heliyon (2024) Vol. 10, Iss. 15, pp. e35331-e35331
Open Access | Times Cited: 1
Development of a colorimetric assay for quantification of favipiravir in human serum using ferrihydrite
Yukiko Moriiwa, Natsu Oyama, Ryo Otsuka, et al.
Talanta (2022) Vol. 252, pp. 123827-123827
Closed Access | Times Cited: 7
Yukiko Moriiwa, Natsu Oyama, Ryo Otsuka, et al.
Talanta (2022) Vol. 252, pp. 123827-123827
Closed Access | Times Cited: 7
Overview of Antiviral Drug Therapy for COVID-19: Where Do We Stand?
Renata Esposito, Davida Mirra, Liberata Sportiello, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2815-2815
Open Access | Times Cited: 7
Renata Esposito, Davida Mirra, Liberata Sportiello, et al.
Biomedicines (2022) Vol. 10, Iss. 11, pp. 2815-2815
Open Access | Times Cited: 7
Better design leads to better results – Importance of virological outcome design in clinical trials for antiviral treatment of coronavirus disease 2019
Getu Zhaori, Lu Lu, Chunyan Liu, et al.
Pediatric Investigation (2023) Vol. 7, Iss. 1, pp. 1-5
Open Access | Times Cited: 3
Getu Zhaori, Lu Lu, Chunyan Liu, et al.
Pediatric Investigation (2023) Vol. 7, Iss. 1, pp. 1-5
Open Access | Times Cited: 3
Extracellular Vesicle-Based SARS-CoV-2 Vaccine
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Yasunari Matsuzaka, Ryu Yashiro
Vaccines (2023) Vol. 11, Iss. 3, pp. 539-539
Open Access | Times Cited: 3
Molecular insights into the sensing function of an oxidized graphene flake for the adsorption of Avigan antiviral drug
Renzon Daniel Cosme Pecho, Narjes Hajali, Ruben Dario Tapia-Silguera, et al.
Computational and Theoretical Chemistry (2023) Vol. 1227, pp. 114240-114240
Closed Access | Times Cited: 3
Renzon Daniel Cosme Pecho, Narjes Hajali, Ruben Dario Tapia-Silguera, et al.
Computational and Theoretical Chemistry (2023) Vol. 1227, pp. 114240-114240
Closed Access | Times Cited: 3
SARS-CoV-2 Pandemic-Therapeutics in Warp Speed
Sourav Sen, Nitin Kumar
Recent Advances in Anti-Infective Drug Discovery (2023) Vol. 18, Iss. 2, pp. 110-119
Closed Access | Times Cited: 2
Sourav Sen, Nitin Kumar
Recent Advances in Anti-Infective Drug Discovery (2023) Vol. 18, Iss. 2, pp. 110-119
Closed Access | Times Cited: 2
The role of cholesterol 25-hydroxylase in viral infections: Mechanisms and implications
Parastoo Yousefi, Ali Gholami, Mohsen Mehrjo, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154783-154783
Closed Access | Times Cited: 2
Parastoo Yousefi, Ali Gholami, Mohsen Mehrjo, et al.
Pathology - Research and Practice (2023) Vol. 249, pp. 154783-154783
Closed Access | Times Cited: 2
Investigating 4’-Fluorouridine Delivery Via Pegylated Graphene Oxide Nanovehicles as a Promising Treatment Strategy Against Virus Infections: An Ab Initio Analysis
Oluwasegun Chijioke Adekoya, Gbolahan Joseph Adekoya, Wanjun Liu, et al.
(2024)
Closed Access
Oluwasegun Chijioke Adekoya, Gbolahan Joseph Adekoya, Wanjun Liu, et al.
(2024)
Closed Access
Pegylated Graphene Oxide For 4′‐Fluorouridine Delivery: An Ab Initio Approach to Antiviral Therapy
Oluwasegun Chijioke Adekoya, Gbolahan Joseph Adekoya, Wanjun Liu, et al.
Advanced Theory and Simulations (2024)
Open Access
Oluwasegun Chijioke Adekoya, Gbolahan Joseph Adekoya, Wanjun Liu, et al.
Advanced Theory and Simulations (2024)
Open Access
Early antiviral and supervisory dexamethasone treatment improve clinical outcomes of nonsevere COVID-19 patients
Tullaya Sitasuwan, Pochamana Phisalprapa, Weerachai Srivanichakorn, et al.
Medicine (2022) Vol. 101, Iss. 45, pp. e31681-e31681
Open Access | Times Cited: 3
Tullaya Sitasuwan, Pochamana Phisalprapa, Weerachai Srivanichakorn, et al.
Medicine (2022) Vol. 101, Iss. 45, pp. e31681-e31681
Open Access | Times Cited: 3
Phase I Pharmacokinetics Study of Oral Administration of Esperavir® (INN: Molnupiravir) (LLC "PROMOMED RUS", Russia)
Т. Н. Комаров, N. S. Bagaevа, K. K. Karnakova, et al.
Drug development & registration (2024) Vol. 13, Iss. 1, pp. 216-223
Open Access
Т. Н. Комаров, N. S. Bagaevа, K. K. Karnakova, et al.
Drug development & registration (2024) Vol. 13, Iss. 1, pp. 216-223
Open Access
Determination of Favipiravir in Human Blood Plasma by HPLC-MS/MS
Т. Н. Комаров, P. A. Karpova, O. A. Archakova, et al.
Drug development & registration (2023) Vol. 12, Iss. 3, pp. 229-239
Open Access | Times Cited: 1
Т. Н. Комаров, P. A. Karpova, O. A. Archakova, et al.
Drug development & registration (2023) Vol. 12, Iss. 3, pp. 229-239
Open Access | Times Cited: 1
Rapid development and mass production of SARS-CoV-2 neutralizing Chicken egg yolk antibodies with protective efficacy in hamsters
Kai Zhao, binan zhao, Haoran Peng, et al.
Research Square (Research Square) (2023)
Open Access
Kai Zhao, binan zhao, Haoran Peng, et al.
Research Square (Research Square) (2023)
Open Access
Three-dimensional transthoracic echocardiography successfully identified myocardial trabeculation mimicking left ventricular apical thrombus in a patient with COVID-19
Kei Takahashi, Toru Egashira, Toshimi Kageyama, et al.
Journal of Medical Ultrasonics (2023) Vol. 50, Iss. 2, pp. 259-261
Open Access
Kei Takahashi, Toru Egashira, Toshimi Kageyama, et al.
Journal of Medical Ultrasonics (2023) Vol. 50, Iss. 2, pp. 259-261
Open Access
